{"id":"sm-153","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Bone marrow suppression"},{"rate":"10-20%","effect":"Nausea and vomiting"},{"rate":"10-20%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL2096660","moleculeType":"Small molecule","molecularWeight":"695.93"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Sm-153 emits beta radiation that selectively targets cancer cells, causing cell death. This targeted approach minimizes damage to surrounding healthy tissue.","oneSentence":"Sm-153 is a radioactive isotope used for targeted radiation therapy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:56.570Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pain relief in bone metastases"}]},"trialDetails":[{"nctId":"NCT07197645","phase":"PHASE1","title":"Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain","status":"RECRUITING","sponsor":"Telix Pharmaceuticals (Innovations) Pty Limited","startDate":"2025-10-21","conditions":"Bone Pain, Metastatic Bone Tumor, Bone Metastases in Subjects With Advanced Cancer","enrollment":33},{"nctId":"NCT00328614","phase":"PHASE1","title":"Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2003-03","conditions":"Prostate Cancer","enrollment":32},{"nctId":"NCT00365105","phase":"PHASE3","title":"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2006-07-11","conditions":"Breast Cancer, Lung Cancer, Metastatic Cancer","enrollment":261},{"nctId":"NCT06008483","phase":"PHASE1","title":"A Dose Finding Study to Treat Bone Tumor(s)","status":"UNKNOWN","sponsor":"QSAM Therapeutics, Inc.","startDate":"2022-04-05","conditions":"Bone Cancer, Bone Tumor, Solid Tumor","enrollment":17},{"nctId":"NCT04833517","phase":"","title":"Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)","status":"UNKNOWN","sponsor":"Universität des Saarlandes","startDate":"2016-01-01","conditions":"Prostate Cancer Metastatic, Castration Resistant Prostatic Cancer, Advanced Prostate Carcinoma","enrollment":500},{"nctId":"NCT03612466","phase":"PHASE1","title":"A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy","status":"WITHDRAWN","sponsor":"Albert Einstein College of Medicine","startDate":"2022-08","conditions":"Osteosarcoma, Bone Metastases","enrollment":""},{"nctId":"NCT00003086","phase":"PHASE1, PHASE2","title":"Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer","status":"TERMINATED","sponsor":"Louisiana State University Health Sciences Center Shreveport","startDate":"1997-03","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT00245011","phase":"PHASE2","title":"Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2004-10","conditions":"Sarcoma","enrollment":11},{"nctId":"NCT01886105","phase":"PHASE2","title":"Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2013-08-19","conditions":"Metastatic Osteosarcoma","enrollment":4},{"nctId":"NCT00374751","phase":"PHASE1, PHASE2","title":"Effect of Samarium on the Relief of Pain Due to Vertebral Metastases","status":"COMPLETED","sponsor":"New York Presbyterian Brooklyn Methodist Hospital","startDate":"2006-05","conditions":"Cancer, Metastasis, Pain","enrollment":29},{"nctId":"NCT00482378","phase":"PHASE1, PHASE2","title":"Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2005-03-21","conditions":"Multiple Myeloma and Plasma Cell Neoplasm, Pain","enrollment":39},{"nctId":"NCT00551525","phase":"PHASE2","title":"Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-04","conditions":"Prostate Cancer","enrollment":67},{"nctId":"NCT00450619","phase":"PHASE2","title":"153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-02","conditions":"Prostate Cancer","enrollment":44},{"nctId":"NCT00429507","phase":"PHASE2","title":"Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-03","conditions":"Breast Cancer, Bone Metastases","enrollment":12},{"nctId":"NCT00316940","phase":"PHASE1","title":"Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Oncotherapeutics","startDate":"2005-12","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":36},{"nctId":"NCT00602706","phase":"PHASE1, PHASE2","title":"Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2000-01","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":76},{"nctId":"NCT00478075","phase":"PHASE1, PHASE2","title":"Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2005-09","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":50},{"nctId":"NCT00559429","phase":"PHASE1","title":"Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2004-12","conditions":"Prostate Cancer","enrollment":13},{"nctId":"NCT00121095","phase":"PHASE1, PHASE2","title":"Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer","status":"UNKNOWN","sponsor":"Cytogen Corporation","startDate":"2005-07","conditions":"Prostatic Neoplasms","enrollment":69}],"_emaApprovals":[],"_faersSignals":[{"count":6,"reaction":"THROMBOCYTOPENIA"},{"count":4,"reaction":"METASTASES TO LUNG"},{"count":3,"reaction":"ABDOMINAL HERNIA"},{"count":3,"reaction":"ASTHENIA"},{"count":3,"reaction":"BONE PAIN"},{"count":3,"reaction":"BREAST CANCER METASTATIC"},{"count":3,"reaction":"CANCER PAIN"},{"count":3,"reaction":"FATIGUE"},{"count":3,"reaction":"ILEUS"},{"count":3,"reaction":"METASTASES TO CENTRAL NERVOUS SYSTEM"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Samarium-153"],"phase":"phase_3","status":"active","brandName":"Sm-153","genericName":"Sm-153","companyName":"Radiation Therapy Oncology Group","companyId":"radiation-therapy-oncology-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sm-153 is a radioactive isotope used for targeted radiation therapy. Used for Pain relief in bone metastases.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}